Medical device companies Medtronic and Volcano plan to develop money-saving hospital contracts that combine complementary products from each company’s interventional cardiology portfolios. Medical device heavyweights Medtronic (NYSE:MDT) and Volcano (NSDQ:VOLC) announced a new alliance to develop budget-friendly hospital contracts for devices that target coronary artery disease. The companies will mingle their product portfolios in unique U.S. contract offerings that provide devices for interventional cardiologists, cardiac catheterization laboratory managers and cardiovascular service line directors, according to a press release.
